摘要
目的探讨硝苯地平联合硫酸镁治疗妊娠高血压的临床效果。方法选取2022年1月至2023年1月枣庄市峄城区底阁镇中心卫生院收治的74例妊娠高血压患者,按照抽签法分为参照组与试验组,每组各37例。参照组采用硫酸镁治疗,试验组采用硝苯地平联合硫酸镁治疗。比较两组血压水平及不良妊娠结局总发生率。结果治疗后,试验组收缩压及舒张压水平均低于参照组(P<0.05)。试验组不良妊娠结局总发生率低于参照组(P<0.05)。结论硝苯地平联合硫酸镁治疗妊娠高血压的临床效果确切,可有效控制血压水平、改善妊娠结局。
Objective To investigate the clinical effect of Nifedipine combined with Magnesium Sulfate in the treatment of pregnancy-induced hypertension.Methods A total of 74 patients with pregnancy-induced hypertension admitted to Dige Town Health Center of Yicheng District of Zaozhuang City from January 2022 to January 2023 were selected and divided into the reference group and the experimental group according to the lottery method,with 37 cases in each group.The reference group was treated with Magnesium Sulfate,and the experimental group was treated with Nifedipine combined with Magnesium Sulfate.Blood pressure levels and total incidence of adverse pregnancy outcomes were compared between the two groups.Results After treatment,the levels of systolic and diastolic blood pressure in the experimental group were lower than those in the reference group(P<0.05).The total incidence of adverse pregnancy outcomes in experimental group was lower than that in the reference group(P<0.05).Conclusion Nifedipine combined with Magnesium Sulfate in the treatment of pregnancy-induced hypertension has definite clinical effect,which can effectively control blood pressure level and improve pregnancy outcomes.
作者
周中芹
ZHOU Zhongqin(Department of Obstetrics and Gynecology,Dige Town Health Center of Yicheng District of Zaozhuang City,Shandong Province,Zaozhuang 277314,China)
出处
《妇儿健康导刊》
2023年第15期128-130,共3页
JOURNAL OF WOMEN AND CHILDREN'S HEALTH GUIDE
关键词
妊娠高血压
硝苯地平
硫酸镁
不良妊娠结局
Pregnancy-induced hypertension
Nifedipine
Magnesium Sulfate
Adverse pregnancy outcome